TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building October 22, 1999